Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
237.00    0.50 (0.21%)
Bid:
235.00
Ask:
238.00
Spread: 3.00 (1.277%)
Market Cap: £75.81m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

20 Apr 2026 16:32

RNS Number : 1867B
Braemar PLC
20 April 2026
 

 

20 April 2026

BRAEMAR PLC

("Braemar" the "Company")

 

PDMR Share Dealing

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that on 17 April 2026, James Gundy, Group Chief Executive Officer, exercised 218,750 nil cost options ("Options") granted under the Company's Long Term Incentive Plan ("LTIP") as set out below:

 

LTIP award grant date

 

Vesting date

Two-year holding period end date

 

Number of Options exercised

24 July 2020

24 July 2023

24 July 2025

218,750

 

 

The 2020 LTIP award vested following the assessment of the applicable performance conditions which were disclosed in the 2023 remuneration report (page 83), this report is available on the Company's website at Financial Reports - Braemar.

 

The exercise of the Options under the LTIP, has been satisfied through the allocation of existing ordinary shares held by the Braemar Employee Share Ownership Plan; as such, no new ordinary shares have been issued. In order to cover tax and national insurance liabilities arising from the exercise of the Options, James Gundy sold 103,088 shares on 17 April 2026 and retained the balance of 115,662 shares.

Following the above transactions, James Gundy's total shareholding is now 1,139,695 (being 3.4% of the Company's issued share capital).

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, contact:

 

Braemar Plc

Tel: +44 (0)20 3142 4100

James Gundy, Group Chief Executive Officer

Grant Foley, Group Chief Financial & Operating Officer

Rebecca-Joy Wekwete, Company Secretary

Houston

Tel: +44 (0)20 4529 0549

Kate Hoare / Charlie Barker / Polly Clarke

Tel: +44 (0)77 3303 2695

braemar@houston.co.uk

Canaccord Genuity

Tel: +44 (0) 20 7523 8000

Adam James / Harry Rees

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

James Gundy

 

Reason for the notification

Position/status

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Exercise of Options granted under the Company's LTIP in 2020

Price(s) and volume(s)

Price: £0.00

 

Volume: 218,750

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £0.00

 

Volume: 218,750

Date of the transaction

17 April 2026

 

Place of the transaction 

Exercise of Options occurred outside a trading venue

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Sale of shares to cover tax and national insurance following exercise of Options granted under the Company's LTIP in 2020

 

Price(s) and volume(s)

Price: £2.202792

 

Volume: 103,088

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £227,081.42

 

Volume: 103,088

Date of the transaction

17 April 2026

 

Place of the transaction 

London Stock Exchange (XLON)

 

 

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice to the shipping and energy markets that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGZDKGGGVZM
Date   Source Headline
10th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20252:47 pmRNSGrant of Share Incentives to PDMRs
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20254:15 pmRNSDirector/PDMR Shareholding
2nd Jul 20254:07 pmRNSResults of 2025 Annual General Meeting
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:01 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 202511:11 amRNSInvestigation Update
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20251:42 pmRNSNotice of 2025 Annual General Meeting
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20254:50 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:01 amRNSCommencement of Share Buyback Programme
29th May 20257:00 amRNSFY25 Final Results
20th May 202510:00 amRNS-RInvestor Presentation at Mello London
15th May 20257:00 amRNSNotice of FY25 Results
2nd May 202512:14 pmRNSTotal Voting Rights
1st Apr 20253:43 pmRNSTotal Voting Rights
24th Mar 20257:00 amRNSFY25 Trading Update
7th Mar 20257:00 amRNSDirectorate Change
28th Feb 20259:04 amRNSTotal Voting Rights
31st Jan 20253:14 pmRNSTotal Voting Rights
31st Dec 20247:00 amRNSTotal Voting Rights
17th Dec 202410:23 amRNSHolding(s) in Company
10th Dec 20244:48 pmRNSHolding(s) in Company
10th Dec 20244:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20249:27 amRNSTotal Voting Rights
28th Nov 20244:17 pmRNSPDMR Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.